Browse all practice questions for the ONS ONCC Chemotherapy Renewal Practice Exam. Search by topic, open any question and review its full explanation, then test yourself in the practice quiz.

ONS ONCC Chemotherapy Renewal Practice Exam course image
All questions

These questions are part of the practice quiz. Start practicing

  • What hepatic function markers are evaluated to decide dose reductions in hepatic impairment?
  • For extravasation of plant alkaloids such as vinblastine and vincristine, which agent is used as an antidote?
  • LVEF monitoring in regimens including Perjeta and trastuzumab should include assessment at baseline and at what interval during neoadjuvant therapy?
  • Which statement about growth factor support in high-risk regimens is true?
  • What is a common central venous line care practice to maintain patency?
  • Which of the following is recommended prophylaxis for at‑risk patients?
  • During a paclitaxel infusion, the patient develops throat clearing and shortness of breath. What is the first immediate action?
  • Which statement best summarizes the purpose of documenting adverse events during chemotherapy?
  • Which symptom cluster is most characteristic of mucositis during chemotherapy?
  • What is the recommended management for extravasation of taxanes such as docetaxel and paclitaxel?
  • Which two agents are categorized as irritants and prompt consideration of a central access port?
  • What is tumor lysis syndrome and what prophylaxis is commonly used?
  • Which action should be taken for a suspected high-risk oncology emergency?
  • How should central line patency be confirmed before chemotherapy administration?
  • What should be included in post-therapy documentation after a chemotherapy session?
  • Which scenario best demonstrates appropriate use of two-person verification in chemotherapy administration?
  • Which statement about vesicant extravasation signs is true?
  • Which statement best describes labeling and disposal of cytotoxic waste?
  • Why is AUC preferred over BSA for carboplatin dosing?
  • Which of the following is a DNA-binding antineoplastic agent?
  • What is the primary purpose of growth factor support in high-risk chemotherapy regimens?
  • Which of the following is a potential positive effect of evidence-based practice?
  • Which formula is most commonly used in the United States to estimate GFR for dosing carboplatin, and what parameters does it include?
  • Trastuzumab and pertuzumab have the potential to cause decline in which organ function?
  • In TLS management, rasburicase is preferred in which patients?
  • How should a nurse respond to suspected infusion reaction during chemotherapy infusion?
  • Which domain is included in a comprehensive geriatric assessment?
  • How should a medication order be verified prior to administration of chemotherapy?
  • What is an example of a high-risk oncology emergency requiring rapid treatment?
  • Which vaccination is recommended for infection prevention in at‑risk patients?
  • Which statement best describes vesicants?
  • According to NCCN Older Adult Oncology Guidelines (version 1.2015), more than 60% of cancers in the United States occur in people age ____ and older.
  • Nadir timing influences laboratory monitoring during chemotherapy by guiding the timing of which test?
  • Which of the following is not typically seen with the regimen including docetaxel, carboplatin, trastuzumab, and pertuzumab?
  • Which agents require caution in pregnancy due to fetal harm?
  • Which chemotherapy agents are most associated with chemotherapy-induced peripheral neuropathy?
  • In the administration of the FOLFOX6 regimen, which component is given as a bolus before the infusion?
  • Which factor offers the highest risk for developing doxorubicin-related cardiotoxicity?
  • Which electrolyte disturbances are commonly seen with tumor lysis syndrome?
  • What is the primary safety reason for using a containment device during chemo compounding?
  • Which is a sign of venous irritation during vesicant extravasation?
  • The risk of developing colorectal cancer increases markedly after age which value?
  • Is it always required to use a central venous port for irritant chemotherapy?
  • Why is hydration important in TLS prophylaxis?
  • Why are antiemetics given as premedication before chemotherapy?
  • Which scenario requires PPE due to potential release of hazardous drugs into the environment?
  • In tumor lysis syndrome, which electrolyte abnormality is commonly observed?
  • At a cumulative doxorubicin dose of 500 mg/m2, what is the approximate risk of cardiotoxicity?
  • Which medication is listed as an effective treatment for peripheral neuropathy?
  • What are common signs of chemotherapy-induced mucositis?
  • What essential education points should be provided to patients using oral chemotherapy at home?
  • Which practice is not long recommended for infection prevention?
  • What is a critical safety consideration when administering intrathecal chemotherapy?
  • Which management step is commonly used for moderate to severe immune-related adverse events from checkpoint inhibitors?
  • Which drugs are used as urate-lowering therapy in TLS prophylaxis?
  • Which imaging modality is appropriate to assess left ventricular function prior to doxorubicin?
  • Which items are verified in two-person verification before chemotherapy administration?
  • Which agent in R-CHOP is most likely to cause constipation?
  • If neoadjuvant chemotherapy is effective, what surgical option might be possible instead of mastectomy?
  • What is the most important late effect monitoring issue related to doxorubicin?
  • What is the primary clinical benefit of neoadjuvant chemotherapy in breast cancer?
  • Which statement best explains why intrathecal and IV medications should be prepared separately and clearly labeled?
  • Which infection prevention measure is unlikely to be effective?
  • Which extravasation management is recommended for irinotecan?
  • Which interventions are recommended to prevent oral candidiasis in patients with mucositis?
  • Per NCCN guidelines, an older patient with a prior neutropenic episode would be a candidate to receive what to reduce neutropenia risk?
  • If a central line shows signs of occlusion during flushing, which information should be documented as part of the line assessment?
  • What is the recommended dosing method for Hyaluronidase in plant alkaloid extravasation?
  • In Totect dosing for anthracycline extravasation, the dose is based on which parameter?
  • Clinical trials evaluating outcomes in cancer patients found improved overall survival when receiving an RDI at least what percentage?
  • Which patient statement should prompt an immediate clinical assessment during chemotherapy?
  • Which is a unique side effect of oxaliplatin?
  • Which item is appropriate to include in post-therapy documentation besides the basic drug information?
  • What is the recommended treatment for mechlorethamine extravasation?
  • Which class would you not anticipate to be part of premedication for a moderately emetogenic regimen?
  • Nadir timing influences monitoring by guiding the timing of the CBC. Which option correctly identifies the test involved?
  • Which of the following is not recommended for practice in infection prevention?
  • Which component is included in the FOLFOX6 regimen?
  • For home chemotherapy management, what is of utmost importance to include in patient education?
  • Which drug category has no known antidote for extravasation?
  • Regarding the sequencing of therapy, which statement is true about paclitaxel and platinum-containing regimens?
  • What is a responsible practice when a patient reports a missed chemotherapy dose?
  • What is the safest approach to initiating a new chemotherapy order in a patient with a central line?
  • What should be documented after addressing a missed chemotherapy dose?
  • Why is a MUGA scan performed prior to cycle 3 in regimens including pertuzumab?
  • Which antidotes are used for extravasation of anthracyclines and vinca alkaloids, respectively?
  • In tumor lysis syndrome, what is the primary role of rasburicase?
  • What action is recommended when LVEF falls to 45–49% with a ≥10% absolute decrease from baseline during pertuzumab/trastuzumab therapy?
  • What should be included in education about missed doses for home oral chemotherapy?
  • What best practices together reduce catheter-related infections?
  • What is a hallmark of immune-related adverse events requiring multidisciplinary management?
  • Which dietary factor is listed as a risk factor for colorectal cancer?
  • Which inherited familial syndromes are listed as risk factors for colorectal cancer?
  • How should a nurse introduce chemotherapy safety to a patient and family?
  • Name a monoclonal antibody with infusion reaction risk and a management step.
  • What is the appropriate approach to address potential drug interactions between chemotherapy and supportive medications?
  • Which statement about monitoring LV function after completing therapy is correct?
  • What is a critical step to prevent medication misadministration when preparing intrathecal chemotherapy?
  • If blood return is not present at the IV site during suspected extravasation, what may have occurred?
  • What is a critical difference between vesicant and non-vesicant drugs?
  • Which action best reduces infection risk during line access?
  • The Cockcroft-Gault equation for estimating GFR incorporates which patient parameters?
  • What is the dosing schedule for Totect (dexrazoxane) in anthracycline extravasation on Days 1 through 3?
  • What infection precautions are essential for patients with chemotherapy-induced neutropenia?
  • Which agent is more likely to cause a hypersensitivity reaction after multiple prior doses?
  • What dosing considerations are used when hepatic impairment is present?
  • Name an immune checkpoint inhibitor adverse event that requires prompt evaluation.
  • Why was a central venous port chosen for Mrs. Turner’s chemotherapy?
  • Rasburicase lowers uric acid by converting it to which metabolite?
  • Which of the following drugs are vesicants?
  • Which statement about paclitaxel treatment is true?
  • Chemotherapy dosing is often calculated in which units?
  • To review the carboplatin dose calculation, which laboratory result must be available?
  • Which laboratory tests are essential for managing chemotherapy-induced myelosuppression?
  • In neoadjuvant trials, the incidence of LVEF decline with trastuzumab and docetaxel plus pertuzumab was what percentage compared to trastuzumab and docetaxel alone?
  • What is the relevance of USP <800> to handling hazardous drugs in chemotherapy?
  • Which statement correctly identifies an interaction that requires adjustment when combining chemotherapy with another drug?
  • Besides capecitabine, which class may be associated with hand-foot syndrome?
  • How do you calculate Body Surface Area for dosing in adults?
  • Which cytotoxic agent is particularly teratogenic and requires strict contraception and pregnancy testing?
  • Which administration detail for paclitaxel is advised to minimize infusion-related toxicity?
  • A comprehensive geriatric assessment for older cancer patients typically includes which domain?
  • In a patient with catheter-related infection signs, what is an appropriate nursing action?
  • Which item is not typically included in post-therapy chemotherapy documentation?
  • Which factor is most important when adjusting chemotherapy dosing for elderly patients?
  • Which of the following drugs is NOT a DNA-binding agent?
  • Which measure is recommended for practice to prevent infections in at-risk patients?
  • Evidence shows that older patients can safely obtain the same treatment benefits as younger patients when they receive what type of regimens?
  • Which action is a key component of managing chemotherapy-induced mucositis?
  • In thrombocytopenia, which practice helps minimize bleeding risk?
  • What toxicity is of most concern with the first dose of rituximab?
  • For early mucositis, which home care step should the nurse instruct?
  • What is the role of growth factors in chemotherapy?
  • Which of the following is NOT listed as a risk factor for colorectal cancer?
  • During infusion of a monoclonal antibody with infusion-reaction risk, which monitoring is essential?
  • Which statement accurately describes DNA-binding antineoplastic agents in the context of extravasation?
  • Which agent in R-CHOP is most associated with hemorrhagic cystitis?
  • Which statement best describes the primary purpose of hub cleaning during IV therapy?
  • What heating method is commonly recommended to reduce local discomfort and facilitate restarting a peripheral IV after extravasation?
  • Which combination is commonly used for moderately emetogenic regimens?
  • Which of the following is a risk factor for colorectal cancer?
  • Which non-drug-related factor is a risk for mucositis, independent of chemotherapy or radiation agents?
  • Nadir timing in myelosuppression monitoring refers to which of the following?
  • During dose verification, which elements should be compared against the prescription/order?
  • Which of the following is recommended for mucositis care in clinical practice?
  • When should left ventricular function be assessed in patients receiving doxorubicin?
  • Which is the lifetime cumulative dose of doxorubicin that should not be exceeded in a patient receiving cyclophosphamide as part of R-CHOP?
  • How should a nurse respond to a suspected infusion-related reaction to a monoclonal antibody?
  • What is a common feature of PPE for handling chemotherapy spills?
  • Which symptoms may occur if docetaxel extravasates?
  • Which PPE item is essential when handling hazardous drugs to minimize exposure?
  • Prior to initiating doxorubicin, which cardiac assessment is prioritized?
  • During the first administration of a monoclonal antibody, how should infusion reactions be assessed?
  • Given a WBC of 2.1 with neutrophils 22% and bands 4%, what is the ANC?
  • How should a nurse document a suspected hazardous drug spill?
  • What is the correct disposal practice for chemotherapy waste?
  • In a combination chemotherapy plan, which approach best ensures patient safety?
  • Which lifestyle factor puts Mr. Patterson at the greatest risk for developing mucositis?
  • Which practice is specifically used to prevent central line–associated bloodstream infections (CLABSI)?
  • Which chemotherapy agent is commonly associated with hand-foot syndrome?
  • Which item is not included in the standard hazardous drug spill documentation?
  • What is recommended when a patient develops infusion-related symptoms during a monoclonal antibody infusion?
  • Which antidote is used for extravasation of anthracycline chemotherapy?
  • Which supportive measure reduces risk of infection in thrombocytopenic patients?
  • In the FOLFOX6 regimen, what is the duration of the continuous infusion for 5-FU?
  • For anthracycline extravasation treated with the antidote, when should infusion be started after extravasation?
  • What is the most reliable method to verify the correct chemotherapy dose before administration?
  • Which education point is essential for safe handling of oral chemotherapy at home?
  • How can nurses support patients at risk for hand-foot syndrome?
  • What is the correct approach to infection prevention for neutropenia related to chemotherapy?
  • Why is it important to document adverse events during chemotherapy?
  • What is the general approach to dosing of chemotherapy in elderly patients?
  • Which of the following is a risk factor for colon cancer?
  • Which drug listed is a DNA non-binding vesicant?
  • Which scenario reduces the lifetime cumulative dose of doxorubicin to 450 mg/m2?
  • What is the role of prophylactic antiemetics in high-emetogenic chemotherapy?
  • What supportive measures help prevent and treat mucositis in chemotherapy patients?
  • Which laboratory values are critical to monitor for methotrexate toxicity?
  • During platinum-based chemotherapy, which laboratory measurements are most pertinent to assess nephrotoxicity risk?
  • Which treatment regimen is used for colorectal cancer described in the material?
Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy